Eli Lilly & Co. (LLY) Financials Nov 18, 2014, 9:47
Eli Lilly & Co. (LLY) Financials Nov 18, 2014, 9:47 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Eli Lilly & Co.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 21.84B 23.08B 24.29B 22.6B 23.11B
Cost of Goods Sold (COGS) incl. D&A 4.25B 4.37B 5.07B 4.8B 4.91B
COGS excluding D&A 2.95B 3.04B 3.69B 3.33B 3.46B
Depreciation & Amortization Expense 1.3B 1.33B 1.37B 1.46B 1.45B
Depreciation 813.5M 749.1M 732.4M 754M 890.6M
Amortization of Intangibles 484.3M 579.1M 641.2M 708.2M 555M
Gross Income 17.59B 18.71B 19.22B 17.81B 18.21B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.22B 11.94B 12.9B 12.79B 12.66B
Research & Development 4.33B 4.88B 5.02B 5.28B 5.53B
Other SG&A 6.89B 7.05B 7.88B 7.51B 7.13B
Other Operating Expense 0 0 0 0 0
Unusual Expense 782.7M 221M 683M (479.9M) (291M)
EBIT after Unusual Expense (782.7M) (221M) (683M) 479.9M 291M
Non Operating Income/Expense (43.4M) 107.6M (179.3M) (14.2M) 90.6M
Non-Operating Interest Income 75.2M 51.9M 79.9M 105M 119.7M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 261.3M 185.5M 186M 177.8M 160.1M
Gross Interest Expense 291.5M 211.5M 211.7M 198.8M 184.2M
Interest Capitalized 30.2M 26M 25.7M 21M 24.1M
Pretax Income 5.36B 6.53B 5.35B 5.41B 5.89B
Income Tax 1.03B 1.46B 1B 1.32B 1.2B
Income Tax - Current Domestic 94.9M 399.5M 648.5M 653M 385.4M
Income Tax - Current Foreign 772.2M 513.9M 759.5M 540.6M 553.2M
Income Tax - Deferred Domestic 82.1M 597.5M (371.5M) 96.1M 294.1M
Income Tax - Deferred Foreign 79.8M (55.2M) (34.7M) 29.9M (28.2M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.33B 5.07B 4.35B 4.09B 4.68B
Minority Interest Expense 0 0 0 0 0
Net Income 4.33B 5.07B 4.35B 4.09B 4.68B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.33B 5.07B 4.35B 4.09B 4.68B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.33B 5.07B 4.35B 4.09B 4.68B
EPS (Basic) 3.94 4.58 3.90 3.67 4.33
Basic Shares Outstanding 1.1B 1.11B 1.11B 1.11B 1.08B
EPS (Diluted) 3.94 4.58 3.90 3.66 4.32
Diluted Shares Outstanding 1.1B 1.11B 1.11B 1.12B 1.08B
EBITDA 7.67B 8.1B 7.69B 6.48B 6.99B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...
Continue Reading
An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...
Continue Reading
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...
Continue Reading
Top 5 Most Recently Viewed Articles
Harnessing the Future with Innovative Cloud Communications At the forefront of the cloud communications industry, Bandwidth Inc. (NASDAQ: BAND) is unveiling cutting-edge solutions at a prominent conference. With a focus on AI-driven and software-powered cloud communications, Bandwidth is committed to empowering IT leaders with the tools necessary to take charge of their...
Continue Reading
MAIA's Growth and Summer Showcase When you've been in the game for decades, you either pivot to the times or become history. MAIA Management Group, LLC is making sure they're not just sticking around but planning to shape the scene as they announce their Summer Showcase & Relaunch. Mark August 7, 2026, on your calendars folks, because that's when the fireworks go off in...
Continue Reading
Animation Market Overview The global animation industry is experiencing a significant transformation due to the growing demand for digital streaming, immersive gaming experiences, and the rise of e-learning platforms. As of now, the animation market is valued at around USD 462.32 billion, and is expected to rapidly expand to USD 895.71 billion by 2034, illustrating the...
Continue Reading
2025 Earnings Report: Is Farmer Mac Truly Thriving? February 19, 2026, saw Farmer Mac (NYSE: AGM) release its fiscal results for the year ending December 31, 2025. The figures paint a rosy picture at first glance—record business volume growth of $3.8 billion, marking a robust 13% increase year-over-year. This company claims to have pumped $10.5 billion in liquidity to...
Continue Reading
Exciting Launch of APHRANEL in the World of Aesthetics MOYOM Biotechnology proudly announces the highly anticipated APHRANEL Global Launch Meeting, an event set to redefine the landscape of medical aesthetics. Scheduled to take place at the impressive Shanghai World Reception Hall, this occasion is aimed at gathering industry experts, partners, and influential investors...
Continue Reading